Infectious Disease policy updates
Track new and updated Infectious Disease policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Rifapentine (Priftin) coverage and PA criteria | Arizona Complete Health | Clinical | Infectious Disease | Modified | Jan 20, 2020 |
| Concert Infectious Disease: Multisystem Testing (CMV and Metagenomic Sequencing) | Arizona Complete Health | Clinical | Infectious Disease | Modified | — |
| CONCERT INFECTIOUS DISEASE: GENITOURINARY TESTING (vaginitis, vaginosis, UTI) - Coverage Criteria | Arizona Complete Health | Clinical | Infectious Disease | Modified | — |
| Concert Infectious Disease: Primary Care & Preventative Screening (PDF) | Arizona Complete Health | Clinical | Infectious Disease | Modified | — |
| Vector-borne and tropical disease testing — Lyme disease and Zika virus (serologic and molecular testing) | Arizona Complete Health | Clinical | Infectious Disease | Modified | — |
| Respiratory Testing (Lab) — Outpatient diagnostic testing for respiratory pathogens | Arizona Complete Health | Clinical | Infectious Disease | Modified | — |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.